First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study

Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003–2010

(2012) Annika Karlsson et al.   PLoS One

Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS)

(2011) Federico García et al.   ANTIVIRAL RESEARCH

Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure

(2011) Jonathan Z. Li   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

(2011) Linda Wittkop et al.   LANCET INFECTIOUS DISEASES

Increase of Transmitted Drug Resistance among HIV-Infected Sub-Saharan Africans Residing in Spain in Contrast to the Native Population

(2011) Gonzalo Yebra et al.   PLoS One

Transmission of HIV‐1 Drug‐Resistant Variants: Prevalence and Effect on Treatment Outcome

(2010) Martin R. Jakobsen et al.   CLINICAL INFECTIOUS DISEASES

Antiretroviral Treatment of Adult HIV Infection

(2010) Melanie A. Thompson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort

(2010) Barbara Bartmeyer et al.   PLoS One

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

(2009)   AIDS

Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy

(2009) Olivia Peuchant et al.   AIDS

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase

(2009) Mary Kearney et al.   AIDS

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

(2009)   AIDS

The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999–2005

(2009) Anne Margrethe Audelin et al.   ANTIVIRAL THERAPY

Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study

(2009) Wendy P Bannister et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe

(2009) Jurgen Vercauteren et al.   JOURNAL OF INFECTIOUS DISEASES

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

(2009) Birgitte B. Simen et al.   JOURNAL OF INFECTIOUS DISEASES

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

(2009) Diane E. Bennett et al.   PLoS One

Prevalence and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006

(2008) Jurgen Vercauteren et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent Patients

(2008) Karin J. Metzner et al.   CLINICAL INFECTIOUS DISEASES

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

(2008) BG Gazzard et al.   HIV MEDICINE

Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort

(2008) B. A. I. Payne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

(2008) Sharon A. Riddler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy

(2008) Jeffrey A Johnson et al.   PLOS MEDICINE